Literature DB >> 21409354

Anesthetic management of aortocaval fistula repair associated with aortic valve replacement, severe aortic regurgitation, and bacterial endocarditis.

Jahan Porhomayon1, Mahmoud A A Hassan, Padmavathi R Perala, Nader D Nader.   

Abstract

We report a case of an adult male who had received a gunshot to the abdomen 12 years earlier. He presented with manifestations of high-output congestive heart failure (CHF), aortic regurgitation (AR), and pulmonary septic embolism. Further investigation revealed an aortocaval fistula (ACF). Following endovascular repair of the ACF, we observed an immediate rise in systemic vascular resistance (SVR), decrease in central venous pressure (CVP), increase in regurgitant flow across the aortic valve, and decrease in central mixed venous oxygenation. A combination of vasodilators and vasopressors was used to maintain hemodynamics. Milrinone infusion was necessary after cardiopulmonary bypass to maintain cardiac output. Even though local anesthesia and light sedation were used for ACF closure, the hemodynamics changed dramatically throughout the procedure. ACF closure under local anesthesia and sedation is preferred because the hemodynamics alterations under local anesthesia are less severe. The rise in SVR and regurgitant flow across aortic valve is less dramatic. As a result, hemodynamic management and separation from cardiopulmonary bypass are easier.

Entities:  

Mesh:

Year:  2011        PMID: 21409354     DOI: 10.1007/s00540-011-1104-9

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  13 in total

1.  Anaesthetic implications of endovascular repair of aortocaval fistula.

Authors:  M L Sharma; K A George; J A Gamble
Journal:  Anaesthesia       Date:  2000-07       Impact factor: 6.955

2.  Anesthetic implications of surgical repair of an aortocaval fistula.

Authors:  Praveen Kumar Neema; Subramaniam Ramakrishnan; Prabhat Kumar Sinha; Ramesh Chandra Rathod
Journal:  J Cardiothorac Vasc Anesth       Date:  2003-04       Impact factor: 2.628

3.  Cardiac surgery in bacterial endocarditis.

Authors:  W B Stason; R W DeSanctis; A N Weinberg; W G Austen
Journal:  Circulation       Date:  1968-09       Impact factor: 29.690

4.  Anaesthetic hazards of aortocaval fistula.

Authors:  A Bodenham
Journal:  Br J Anaesth       Date:  1990-11       Impact factor: 9.166

5.  Echocardiography predicts embolic events in infective endocarditis.

Authors:  G Di Salvo; G Habib; V Pergola; J F Avierinos; E Philip; J P Casalta; J M Vailloud; G Derumeaux; J Gouvernet; P Ambrosi; M Lambert; A Ferracci; D Raoult; R Luccioni
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

Review 6.  Delayed presentation of traumatic aortocaval fistula: a report of two cases and a review of the associated compensatory hemodynamic and structural changes.

Authors:  Todd A Spencer; Stephen H Smyth; Gerard Wittich; Glenn C Hunter
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

7.  Anesthetic management of a patient with aortocaval fistula.

Authors:  Keiko Morikawa; Hidekazu Setoguchi; Jun Yoshino; Masaiwa Motoyama; Reiko Makizono; Tomoka Yokoo; Yasuhiko Suemori; Hiroyuki Tanaka; Shosuke Takahashi
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

Review 8.  Current best practices and guidelines indications for surgical intervention in infective endocarditis.

Authors:  Lars Olaison; Gösta Pettersson
Journal:  Infect Dis Clin North Am       Date:  2002-06       Impact factor: 5.982

9.  [Surgery in acute bacterial endocarditis. Restraints--possibilities].

Authors:  G Dreyfus
Journal:  Arch Mal Coeur Vaiss       Date:  1993-12

10.  Aortocaval and iliac arteriovenous fistulas: recognition and treatment.

Authors:  D C Brewster; R P Cambria; A C Moncure; R C Darling; G M LaMuraglia; S C Geller; W M Abbott
Journal:  J Vasc Surg       Date:  1991-02       Impact factor: 4.268

View more
  1 in total

1.  Spontaneous aortocaval fistula due to ruptured infrarenal aortic aneurysm.

Authors:  A Afshar Far; A Amir Derakhshanfar; Kh Atqiaee; S Lotfolah Zadeh; M R Sobhiyeh; S Jabbehdari
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.